Adherium Ltd. engages in the development, manufacture, and supply of connected medical devices and respiratory medications used by patients, pharmaceutical companies, healthcare providers, and contract research organizations. The firm's Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD. The company was founded by Garth Sutherland in 2001 and is headquartered in Auckland, New Zealand.
ASX